CATALOG PRODUCT FINDER

SEARCH BY KEYWORD:

SEARCH BY SCIENTIFIC FIELD:

SARS-CoV-2 Spike Products

Select your SARS-CoV-2 Spike products including PepMix™ Peptide Pools, RepliTope™ Peptide Microarrays and Antigen Peptides!

PepMix™ Peptide Pools

EMPS-229E-S-1

Epitope Mapping Peptide Set HCoV-229E (Spike Glycoprotein)
Set of 50 Matrix Pools and 291 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus 229E (HCoV-229E) for epitope identification and mapping

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	Human coronavirus 229E (HCoV-229E)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	291

Further Information:

Amount	50 Matrix pools and 291 individual peptide aliquots (5 µg each)
Specifications	Peptide scan (optimized scan into 15 mers)
Documentation	Protocol, Datasheet and Annotations
Swiss-Prot ID	P15423, release 2019_12
Sequence	MFVLLVAYALLHIAGCQTTNGLNTSYSV CNGCVGYSENVFAVESGGYIPSDFAFNN WFLLTNTSSVVDGVVRSFQPLLLNCLWS VSGLRFTTGFVYFNGTGRGDCKGFSSDV LSDVIRYNLNFEENLRRGTILFKTSYGV VVFYCTNNTLVSGDAHIPFGTVLGNFYC FVNTTIGNETTSAFVGALPKTVREFVIS RTGHFYINGYRYFTLGNVEAVNFNVTTA ETTDFCTVALASYADVLVNVSQTSIANI IYCNSVINRLRCDQLSFDVPDGFYSTSP IQSVELPVSIVSLPVYHKHTFIVLYVDF KPQSGGGKCFNCYPAGVNITLANFNETK GPLCVDTSHFTTKYVAVYANVGRWSASI NTGNCPFSFGKVNNFVKFGSVCFSLKDI PGGCAMPIVANWAYSKYYTIGSLYVSWS DGDGITGVPQPVEGVSSFMNVTLDKCTK YNIYDVSGVGVIRVSNDTFLNGITYTST SGNLLGFKDVTKGTIYSITPCNPPDQLV VYQQAVVGAMLSENFTSYGFSNVVELPK FFYASNGTYNCTDAVLTYSSFGVCADGS IIAVQPRNVSYDSVSAIVTANLSIPSNW TTSVQVEYLQITSTPIVVDCSTYVCNGN VRCVELLKQYTSACKTIEDALRNSARLE SADVSEMLTFDKKAFTLANVSSFGDYNL SSVIPSLPTSGSRVAGRSAIEDILFSKL VTSGLGTVDADYKKCTKGLSIADLACAQ YYNGIMVLPGVADAERMAMYTGSLIGGI ALGGLTSAVSIPFSLAIQARLNYVALQT DVLQENQKILAASFNKAMTNIVDAFTGV NDAITQTSQALQTVATALNKIQDVVNQQ GNSLNHLTSQLRQNFQAISSSIQAIYDR LDTIQADQQVDRLITGRLAALNVFVSHT LTKYTEVRASRQLAQQKVNECVKSQSKR YGFCGNGTHIFSIVNAAPEGLVFLHTVL LPTQYKDVEAWSGLCVDGTNGYVLRQPN LALYKEGNYYRITSRIMFEPRIPTMADF VQIENCNVTFVNISRSELQTIVPEYIDV NKTLQELSYKLPNYTVPDLVVEQYNQTI LNLTSEISTLENKSAELNYTVQKLQTLI DNINSTLVDLKWLNRVETYIKWPWWVWL CISVVLIFVVSMLLLCCCSTGCCGFFSC FASSIRGCCESTKLPYYDVEKIHIQ
Protein Length (aa)	1173

3.600,00 €

EMPS-HKU1-S-1

Epitope Mapping Peptide Set HCoV-HKU1 (Spike Glycoprotein)
Set of 52 Matrix Pools and 337 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus HKU1 (HCoV-HKU1) for epitope identification and mapping

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	Human coronavirus HKU1 (HCoV-HKU1)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	337

Further Information:

Amount	52 Matrix pools and 337 individual peptide aliquots (5 µg each)
Specifications	Peptide scan (optimized scan into 15 mers)
Documentation	Protocol, Datasheet and Annotations
Swiss-Prot ID	Q5MQD0, release 2019_12
Sequence	MLLIIFILPTTLAVIGDFNCTNFAINDL NTTVPRISEYVVDVSYGLGTYYILDRVY LNTTILFTGYFPKSGANFRDLSLKGTTY LSTLWYQKPFLSDFNNGIFSRVKNTKLY VNKTLYSEFSTIVIGSVFINNSYTIVVQ PHNGVLEITACQYTMCEYPHTICKSKGS SRNESWHFDKSEPLCLFKKNFTYNVSTD WLYFHFYQERGTFYAYYADSGMPTTFLF SLYLGTLLSHYYVLPLTCNAISSNTDNE TLQYWVTPLSKRQYLLKFDNRGVITNAV DCSSSFFSEIQCKTKSLLPNTGVYDLSG FTVKPVATVHRRIPDLPDCDIDKWLNNF NVPSPLNWERKIFSNCNFNLSTLLRLVH TDSFSCNNFDESKIYGSCFKSIVLDKFA IPNSRRSDLQLGSSGFLQSSNYKIDTTS SSCQLYYSLPAINVTINNYNPSSWNRRY GFNNFNLSSHSVVYSRYCFSVNNTFCPC AKPSFASSCKSHKPPSASCPIGTNYRSC ESTTVLDHTDWCRCSCLPDPITAYDPRS CSQKKSLVGVGEHCAGFGVDEEKCGVLD GSYNVSCLCSTDAFLGWSYDTCVSNNRC NIFSNFILNGINSGTTCSNDLLQPNTEV FTDVCVDYDLYGITGQGIFKEVSAVYYN SWQNLLYDSNGNIIGFKDFVTNKTYNIF PCYAGRVSAAFHQNASSLALLYRNLKCS YVLNNISLTTQPYFDSYLGCVFNADNLT DYSVSSCALRMGSGFCVDYNSPSSSSSR RKRRSISASYRFVTFEPFNVSFVNDSIE SVGGLYEIKIPTNFTIVGQEEFIQTNSP KVTIDCSLFVCSNYAACHDLLSEYGTFC DNINSILDEVNGLLDTTQLHVADTLMQG VTLSSNLNTNLHFDVDNINFKSLVGCLG PHCGSSSRSFFEDLLFDKVKLSDVGFVE AYNNCTGGSEIRDLLCVQSFNGIKVLPP ILSESQISGYTTAATVAAMFPPWSAAAG IPFSLNVQYRINGLGVTMDVLNKNQKLI ATAFNNALLSIQNGFSATNSALAKIQSV VNSNAQALNSLLQQLFNKFGAISSSLQE ILSRLDALEAQVQIDRLINGRLTALNAY VSQQLSDISLVKFGAALAMEKVNECVKS QSPRINFCGNGNHILSLVQNAPYGLLFM HFSYKPISFKTVLVSPGLCISGDVGIAP KQGYFIKHNDHWMFTGSSYYYPEPISDK NVVFMNTCSVNFTKAPLVYLNHSVPKLS DFESELSHWFKNQTSIAPNLTLNLHTIN ATFLDLYYEMNLIQESIKSLNNSYINLK DIGTYEMYVKWPWYVWLLISFSFIIFLV LLFFICCCTGCGSACFSKCHNCCDEYGG HHDFVIKTSHDD
Protein Length (aa)	1356

3.600,00 €

EMPS-NL63-S-1

Epitope Mapping Peptide Set HCoV-NL63 (Spike Glycoprotein)
Set of 52 Matrix Pools and 337 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus NL63 (HCoV-NL63) for epitope identification and mapping

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	Human coronavirus NL63 (HCoV-NL63)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	337

Further Information:

Amount	52 Matrix pools and 337 individual peptide aliquots (5 µg each)
Specifications	Peptide scan (optimized scan into 15 mers)
Documentation	Protocol, Datasheet and Annotations
Swiss-Prot ID	Q6Q1S2, release 2019_12
Sequence	MKLFLILLVLPLASCFFTCNSNANLSML QLGVPDNSSTIVTGLLPTHWFCANQSTS VYSANGFFYIDVGNHRSAFALHTGYYDA NQYYIYVTNEIGLNASVTLKICKFSRNT TFDFLSNASSSFDCIVNLLFTEQLGAPL GITISGETVRLHLYNVTRTFYVPAAYKL TKLSVKCYFNYSCVFSVVNATVTVNVTT HNGRVVNYTVCDDCNGYTDNIFSVQQDG RIPNGFPFNNWFLLTNGSTLVDGVSRLY QPLRLTCLWPVPGLKSSTGFVYFNATGS DVNCNGYQHNSVVDVMRYNLNFSANSLD NLKSGVIVFKTLQYDVLFYCSNSSSGVL DTTIPFGPSSQPYYCFINSTINTTHVST FVGILPPTVREIVVARTGQFYINGFKYF DLGFIEAVNFNVTTASATDFWTVAFATF VDVLVNVSATNIQNLLYCDSPFEKLQCE HLQFGLQDGFYSANFLDDNVLPETYVAL PIYYQHTDINFTATASFGGSCYVCKPHQ VNISLNGNTSVCVRTSHFSIRYIYNRVK SGSPGDSSWHIYLKSGTCPFSFSKLNNF QKFKTICFSTVEVPGSCNFPLEATWHYT SYTIVGALYVTWSEGNSITGVPYPVSGI REFSNLVLNNCTKYNIYDYVGTGIIRSS NQSLAGGITYVSNSGNLLGFKNVSTGNI FIVTPCNQPDQVAVYQQSIIGAMTAVNE SRYGLQNLLQLPNFYYVSNGGNNCTTAV MTYSNFGICADGSLIPVRPRNSSDNGIS AIITANLSIPSNWTTSVQVEYLQITSTP IVVDCATYVCNGNPRCKNLLKQYTSACK TIEDALRLSAHLETNDVSSMLTFDSNAF SLANVTSFGDYNLSSVLPQRNIRSSRIA GRSALEDLLFSKVVTSGLGTVDVDYKSC TKGLSIADLACAQYYNGIMVLPGVADAE RMAMYTGSLIGGMVLGGLTSAAAIPFSL ALQARLNYVALQTDVLQENQKILAASFN KAINNIVASFSSVNDAITQTAEAIHTVT IALNKIQDVVNQQGSALNHLTSQLRHNF QAISNSIQAIYDRLDSIQADQQVDRLIT GRLAALNAFVSQVLNKYTEVRGSRRLAQ QKINECVKSQSNRYGFCGNGTHIFSIVN SAPDGLLFLHTVLLPTDYKNVKAWSGIC VDGIYGYVLRQPNLVLYSDNGVFRVTSR VMFQPRLPVLSDFVQIYNCNVTFVNISR VELHTVIPDYVDVNKTLQEFAQNLPKYV KPNFDLTPFNLTYLNLSSELKQLEAKTA SLFQTTVELQGLIDQINSTYVDLKLLNR FENYIKWPWWVWLIISVVFVVLLSLLVF CCLSTGCCGCCNCLTSSMRGCCDCGSTK LPYYEFEKVHVQ
Protein Length (aa)	1356

3.600,00 €

EMPS-OC43-S-1

Epitope Mapping Peptide Set HCoV-OC43 (Spike Glycoprotein)
Set of 52 Matrix Pools and 336 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus OC43 (HCoV-OC43) for epitope identification and mapping

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	Human coronavirus OC43 (HCoV-OC43)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	336

Further Information:

Amount	52 Matrix pools and 336 individual peptide aliquots (5 µg each)
Specifications	Peptide scan (optimized scan into 15 mers)
Documentation	Protocol, Datasheet and Annotations
Swiss-Prot ID	P36334, release 2020_02
Sequence	MFLILLISLPTAFAVIGDLKCTSDNIND KDTGPPPISTDTVDVTNGLGTYYVLDRV YLNTTLFLNGYYPTSGSTYRNMALKGSV LLSRLWFKPPFLSDFINGIFAKVKNTKV IKDRVMYSEFPAITIGSTFVNTSYSVVV QPRTINSTQDGDNKLQGLLEVSVCQYNM CEYPQTICHPNLGNHRKELWHLDTGVVS CLYKRNFTYDVNADYLYFHFYQEGGTFY AYFTDTGVVTKFLFNVYLGMALSHYYVM PLTCNSKLTLEYWVTPLTSRQYLLAFNQ DGIIFNAEDCMSDFMSEIKCKTQSIAPP TGVYELNGYTVQPIADVYRRKPNLPNCN IEAWLNDKSVPSPLNWERKTFSNCNFNM SSLMSFIQADSFTCNNIDAAKIYGMCFS SITIDKFAIPNGRKVDLQLGNLGYLQSF NYRIDTTATSCQLYYNLPAANVSVSRFN PSTWNKRFGFIEDSVFKPRPAGVLTNHD VVYAQHCFKAPKNFCPCKLNGSCVGSGP GKNNGIGTCPAGTNYLTCDNLCTPDPIT FTGTYKCPQTKSLVGIGEHCSGLAVKSD YCGGNSCTCRPQAFLGWSADSCLQGDKC NIFANFILHDVNSGLTCSTDLQKANTDI ILGVCVNYDLYGILGQGIFVEVNATYYN SWQNLLYDSNGNLYGFRDYIINRTFMIR SCYSGRVSAAFHANSSEPALLFRNIKCN YVFNNSLTRQLQPINYFDSYLGCVVNAY NSTAISVQTCDLTVGSGYCVDYSKNRRS RGAITTGYRFTNFEPFTVNSVNDSLEPV GGLYEIQIPSEFTIGNMVEFIQTSSPKV TIDCAAFVCGDYAACKSQLVEYGSFCDN INAILTEVNELLDTTQLQVANSLMNGVT LSTKLKDGVNFNVDDINFSPVLGCLGSE CSKASSRSAIEDLLFDKVKLSDVGFVEA YNNCTGGAEIRDLICVQSYKGIKVLPPL LSENQISGYTLAATSASLFPPWTAAAGV PFYLNVQYRINGLGVTMDVLSQNQKLIA NAFNNALYAIQEGFDATNSALVKIQAVV NANAEALNNLLQQLSNRFGAISASLQEI LSRLDALEAEAQIDRLINGRLTALNAYV SQQLSDSTLVKFSAAQAMEKVNECVKSQ SSRINFCGNGNHIISLVQNAPYGLYFIH FSYVPTKYVTARVSPGLCIAGDRGIAPK SGYFVNVNNTWMYTGSGYYYPEPITENN VVVMSTCAVNYTKAPYVMLNTSIPNLPD FKEELDQWFKNQTSVAPDLSLDYINVTF LDLQVEMNRLQEAIKVLNQSYINLKDIG TYEYYVKWPWYVWLLICLAGVAMLVLLF FICCCTGCGTSCFKKCGGCCDDYTGYQE LVIKTSHDD
Protein Length (aa)	1353

3.600,00 €

EMPS-WCPV-S-1

Epitope Mapping Peptide Set SARS-CoV-2 (Spike Glycoprotein)
Set of 52 Matrix Pools and 315 individual overlapping peptides spanning the whole Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for epitope identification and mapping.

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	315

Further Information:

Amount	52 Matrix pools and 315 individual peptide aliquots (5 µg each)
Specifications	Peptide scan (optimized scan into 15 mers)
Documentation	Protocol, Datasheet and Annotations
Swiss-Prot ID	P0DTC9
Sequence	MFVFLVLLPLVSSQCVNLTTRTQLPPAY TNSFTRGVYYPDKVFRSSVLHSTQDLFL PFFSNVTWFHAIHVSGTNGTKRFDNPVL PFNDGVYFASTEKSNIIRGWIFGTTLDS KTQSLLIVNNATNVVIKVCEFQFCNDPF LGVYYHKNNKSWMESEFRVYSSANNCTF EYVSQPFLMDLEGKQGNFKNLREFVFKN IDGYFKIYSKHTPINLVRDLPQGFSALE PLVDLPIGINITRFQTLLALHRSYLTPG DSSSGWTAGAAAYYVGYLQPRTFLLKYN ENGTITDAVDCALDPLSETKCTLKSFTV EKGIYQTSNFRVQPTESIVRFPNITNLC PFGEVFNATRFASVYAWNRKRISNCVAD YSVLYNSASFSTFKCYGVSPTKLNDLCF TNVYADSFVIRGDEVRQIAPGQTGKIAD YNYKLPDDFTGCVIAWNSNNLDSKVGGN YNYLYRLFRKSNLKPFERDISTEIYQAG STPCNGVEGFNCYFPLQSYGFQPTNGVG YQPYRVVVLSFELLHAPATVCGPKKSTN LVKNKCVNFNFNGLTGTGVLTESNKKFL PFQQFGRDIADTTDAVRDPQTLEILDIT PCSFGGVSVITPGTNTSNQVAVLYQDVN CTEVPVAIHADQLTPTWRVYSTGSNVFQ TRAGCLIGAEHVNNSYECDIPIGAGICA SYQTQTNSPRRARSVASQSIIAYTMSLG AENSVAYSNNSIAIPTNFTISVTTEILP VSMTKTSVDCTMYICGDSTECSNLLLQY GSFCTQLNRALTGIAVEQDKNTQEVFAQ VKQIYKTPPIKDFGGFNFSQILPDPSKP SKRSFIEDLLFNKVTLADAGFIKQYGDC LGDIAARDLICAQKFNGLTVLPPLLTDE MIAQYTSALLAGTITSGWTFGAGAALQI PFAMQMAYRFNGIGVTQNVLYENQKLIA NQFNSAIGKIQDSLSSTASALGKLQDVV NQNAQALNTLVKQLSSNFGAISSVLNDI LSRLDKVEAEVQIDRLITGRLQSLQTYV TQQLIRAAEIRASANLAATKMSECVLGQ SKRVDFCGKGYHLMSFPQSAPHGVVFLH VTYVPAQEKNFTTAPAICHDGKAHFPRE GVFVSNGTHWFVTQRNFYEPQIITTDNT FVSGNCDVVIGIVNNTVYDPLQPELDSF KEELDKYFKNHTSPDVDLGDISGINASV VNIQKEIDRLNEVAKNLNESLIDLQELG KYEQYIKWPWYIWLGFIAGLIAIVMVTI MLCCMTSCCSCLKGCCSCGSCCKFDEDD SEPVLKGVKLHYT
Protein Length (aa)	1273

3.600,00 €

PM-HKU1-S

PepMix™ HCoV- HKU1 (Spike Glycoprotein)
Pool of 327 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus HKU1 (HCoV-HKU1) (isolate N1) for T cell assays (e.g. ELISPOT)

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	Human coronavirus HKU1 (HCoV-HKU1)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	169+168

Further Information:

Amount	2 vials (one of each subpool) containing 15 nmol (appr. 25µg) per peptide
Specifications	Peptide scan (15mers with 11 aa overlap)
Documentation	Protocol and Datasheet
Swiss-Prot ID	Q5MQD0
Sequence	MLLIIFILPTTLAVIGDFNCTNFAINDL NTTVPRISEYVVDVSYGLGTYYILDRVY LNTTILFTGYFPKSGANFRDLSLKGTTY LSTLWYQKPFLSDFNNGIFSRVKNTKLY VNKTLYSEFSTIVIGSVFINNSYTIVVQ PHNGVLEITACQYTMCEYPHTICKSKGS SRNESWHFDKSEPLCLFKKNFTYNVSTD WLYFHFYQERGTFYAYYADSGMPTTFLF SLYLGTLLSHYYVLPLTCNAISSNTDNE TLQYWVTPLSKRQYLLKFDNRGVITNAV DCSSSFFSEIQCKTKSLLPNTGVYDLSG FTVKPVATVHRRIPDLPDCDIDKWLNNF NVPSPLNWERKIFSNCNFNLSTLLRLVH TDSFSCNNFDESKIYGSCFKSIVLDKFA IPNSRRSDLQLGSSGFLQSSNYKIDTTS SSCQLYYSLPAINVTINNYNPSSWNRRY GFNNFNLSSHSVVYSRYCFSVNNTFCPC AKPSFASSCKSHKPPSASCPIGTNYRSC ESTTVLDHTDWCRCSCLPDPITAYDPRS CSQKKSLVGVGEHCAGFGVDEEKCGVLD GSYNVSCLCSTDAFLGWSYDTCVSNNRC NIFSNFILNGINSGTTCSNDLLQPNTEV FTDVCVDYDLYGITGQGIFKEVSAVYYN SWQNLLYDSNGNIIGFKDFVTNKTYNIF PCYAGRVSAAFHQNASSLALLYRNLKCS YVLNNISLTTQPYFDSYLGCVFNADNLT DYSVSSCALRMGSGFCVDYNSPSSSSSR RKRRSISASYRFVTFEPFNVSFVNDSIE SVGGLYEIKIPTNFTIVGQEEFIQTNSP KVTIDCSLFVCSNYAACHDLLSEYGTFC DNINSILDEVNGLLDTTQLHVADTLMQG VTLSSNLNTNLHFDVDNINFKSLVGCLG PHCGSSSRSFFEDLLFDKVKLSDVGFVE AYNNCTGGSEIRDLLCVQSFNGIKVLPP ILSESQISGYTTAATVAAMFPPWSAAAG IPFSLNVQYRINGLGVTMDVLNKNQKLI ATAFNNALLSIQNGFSATNSALAKIQSV VNSNAQALNSLLQQLFNKFGAISSSLQE ILSRLDALEAQVQIDRLINGRLTALNAY VSQQLSDISLVKFGAALAMEKVNECVKS QSPRINFCGNGNHILSLVQNAPYGLLFM HFSYKPISFKTVLVSPGLCISGDVGIAP KQGYFIKHNDHWMFTGSSYYYPEPISDK NVVFMNTCSVNFTKAPLVYLNHSVPKLS DFESELSHWFKNQTSIAPNLTLNLHTIN ATFLDLYYEMNLIQESIKSLNNSYINLK DIGTYEMYVKWPWYVWLLISFSFIIFLV LLFFICCCTGCGSACFSKCHNCCDEYGG HHDFVIKTSHDD
Protein Length (aa)	1356

734,00 €

PM-229E-S

PepMix™ HCoV-229E (Spike Glycoprotein)
Pool of 291 peptides (delivered in two subpools of 146 & 145 peptides) derived from a peptide scan through the entire Spike glycoprotein of Human coronavirus 229E (HCoV-229E) for T cell assays (e.g. ELISPOT)

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	Human coronavirus 229E (HCoV-229E)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	146+145

Further Information:

Amount	2 vials (one of each subpool) containing 15 nmol (appr. 25µg) per peptide
Specifications	Peptide scan (15mers with 11 aa overlap)
Documentation	Protocol and Datasheet
Swiss-Prot ID	P15423
Sequence	MFVLLVAYALLHIAGCQTTNGLNTSYSV CNGCVGYSENVFAVESGGYIPSDFAFNN WFLLTNTSSVVDGVVRSFQPLLLNCLWS VSGLRFTTGFVYFNGTGRGDCKGFSSDV LSDVIRYNLNFEENLRRGTILFKTSYGV VVFYCTNNTLVSGDAHIPFGTVLGNFYC FVNTTIGNETTSAFVGALPKTVREFVIS RTGHFYINGYRYFTLGNVEAVNFNVTTA ETTDFCTVALASYADVLVNVSQTSIANI IYCNSVINRLRCDQLSFDVPDGFYSTSP IQSVELPVSIVSLPVYHKHTFIVLYVDF KPQSGGGKCFNCYPAGVNITLANFNETK GPLCVDTSHFTTKYVAVYANVGRWSASI NTGNCPFSFGKVNNFVKFGSVCFSLKDI PGGCAMPIVANWAYSKYYTIGSLYVSWS DGDGITGVPQPVEGVSSFMNVTLDKCTK YNIYDVSGVGVIRVSNDTFLNGITYTST SGNLLGFKDVTKGTIYSITPCNPPDQLV VYQQAVVGAMLSENFTSYGFSNVVELPK FFYASNGTYNCTDAVLTYSSFGVCADGS IIAVQPRNVSYDSVSAIVTANLSIPSNW TTSVQVEYLQITSTPIVVDCSTYVCNGN VRCVELLKQYTSACKTIEDALRNSARLE SADVSEMLTFDKKAFTLANVSSFGDYNL SSVIPSLPTSGSRVAGRSAIEDILFSKL VTSGLGTVDADYKKCTKGLSIADLACAQ YYNGIMVLPGVADAERMAMYTGSLIGGI ALGGLTSAVSIPFSLAIQARLNYVALQT DVLQENQKILAASFNKAMTNIVDAFTGV NDAITQTSQALQTVATALNKIQDVVNQQ GNSLNHLTSQLRQNFQAISSSIQAIYDR LDTIQADQQVDRLITGRLAALNVFVSHT LTKYTEVRASRQLAQQKVNECVKSQSKR YGFCGNGTHIFSIVNAAPEGLVFLHTVL LPTQYKDVEAWSGLCVDGTNGYVLRQPN LALYKEGNYYRITSRIMFEPRIPTMADF VQIENCNVTFVNISRSELQTIVPEYIDV NKTLQELSYKLPNYTVPDLVVEQYNQTI LNLTSEISTLENKSAELNYTVQKLQTLI DNINSTLVDLKWLNRVETYIKWPWWVWL CISVVLIFVVSMLLLCCCSTGCCGFFSC FASSIRGCCESTKLPYYDVEKIHIQ
Protein Length (aa)	1173

734,00 €

PM-NL63-S-1

PepMix™ HCoV-NL63 (Spike Glycoprotein)
Pool of 337 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus NL63 (HCoV-NL63) for T cell assays (e.g. ELISPOT)

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	Human coronavirus NL63 (HCoV-NL63)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	169+168

Further Information:

Amount	2 vials (one of each subpool) containing 15 nmol (appr. 25µg) per peptide
Specifications	Peptide scan (15mers with 11 aa overlap)
Documentation	Protocol and Datasheet
Swiss-Prot ID	Q6Q1S2
Sequence	MKLFLILLVLPLASCFFTCNSNANLSML QLGVPDNSSTIVTGLLPTHWFCANQSTS VYSANGFFYIDVGNHRSAFALHTGYYDA NQYYIYVTNEIGLNASVTLKICKFSRNT TFDFLSNASSSFDCIVNLLFTEQLGAPL GITISGETVRLHLYNVTRTFYVPAAYKL TKLSVKCYFNYSCVFSVVNATVTVNVTT HNGRVVNYTVCDDCNGYTDNIFSVQQDG RIPNGFPFNNWFLLTNGSTLVDGVSRLY QPLRLTCLWPVPGLKSSTGFVYFNATGS DVNCNGYQHNSVVDVMRYNLNFSANSLD NLKSGVIVFKTLQYDVLFYCSNSSSGVL DTTIPFGPSSQPYYCFINSTINTTHVST FVGILPPTVREIVVARTGQFYINGFKYF DLGFIEAVNFNVTTASATDFWTVAFATF VDVLVNVSATNIQNLLYCDSPFEKLQCE HLQFGLQDGFYSANFLDDNVLPETYVAL PIYYQHTDINFTATASFGGSCYVCKPHQ VNISLNGNTSVCVRTSHFSIRYIYNRVK SGSPGDSSWHIYLKSGTCPFSFSKLNNF QKFKTICFSTVEVPGSCNFPLEATWHYT SYTIVGALYVTWSEGNSITGVPYPVSGI REFSNLVLNNCTKYNIYDYVGTGIIRSS NQSLAGGITYVSNSGNLLGFKNVSTGNI FIVTPCNQPDQVAVYQQSIIGAMTAVNE SRYGLQNLLQLPNFYYVSNGGNNCTTAV MTYSNFGICADGSLIPVRPRNSSDNGIS AIITANLSIPSNWTTSVQVEYLQITSTP IVVDCATYVCNGNPRCKNLLKQYTSACK TIEDALRLSAHLETNDVSSMLTFDSNAF SLANVTSFGDYNLSSVLPQRNIRSSRIA GRSALEDLLFSKVVTSGLGTVDVDYKSC TKGLSIADLACAQYYNGIMVLPGVADAE RMAMYTGSLIGGMVLGGLTSAAAIPFSL ALQARLNYVALQTDVLQENQKILAASFN KAINNIVASFSSVNDAITQTAEAIHTVT IALNKIQDVVNQQGSALNHLTSQLRHNF QAISNSIQAIYDRLDSIQADQQVDRLIT GRLAALNAFVSQVLNKYTEVRGSRRLAQ QKINECVKSQSNRYGFCGNGTHIFSIVN SAPDGLLFLHTVLLPTDYKNVKAWSGIC VDGIYGYVLRQPNLVLYSDNGVFRVTSR VMFQPRLPVLSDFVQIYNCNVTFVNISR VELHTVIPDYVDVNKTLQEFAQNLPKYV KPNFDLTPFNLTYLNLSSELKQLEAKTA SLFQTTVELQGLIDQINSTYVDLKLLNR FENYIKWPWWVWLIISVVFVVLLSLLVF CCLSTGCCGCCNCLTSSMRGCCDCGSTK LPYYEFEKVHVQ
Protein Length (aa)	1356

734,00 €

PM-OC43-S

PepMix™ HCoV-OC43 (Spike Glycoprotein)
Pool of 336 peptides (delivered in two subpools of 168 peptides each) derived from a peptide scan through the entire Spike glycoprotein of Human coronavirus OC43 (HCoV-OC43) for T cell assays (e.g. ELISPOT)

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	Human coronavirus OC43 (HCoV-OC43)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	168+168

Further Information:

Amount	2 vials (one of each subpool) containing 15 nmol (appr. 25µg) per peptide
Specifications	Peptide scan (15mers with 11 aa overlap)
Documentation	Protocol and Datasheet
Swiss-Prot ID	P36334
Sequence	MFLILLISLPTAFAVIGDLKCTSDNIND KDTGPPPISTDTVDVTNGLGTYYVLDRV YLNTTLFLNGYYPTSGSTYRNMALKGSV LLSRLWFKPPFLSDFINGIFAKVKNTKV IKDRVMYSEFPAITIGSTFVNTSYSVVV QPRTINSTQDGDNKLQGLLEVSVCQYNM CEYPQTICHPNLGNHRKELWHLDTGVVS CLYKRNFTYDVNADYLYFHFYQEGGTFY AYFTDTGVVTKFLFNVYLGMALSHYYVM PLTCNSKLTLEYWVTPLTSRQYLLAFNQ DGIIFNAEDCMSDFMSEIKCKTQSIAPP TGVYELNGYTVQPIADVYRRKPNLPNCN IEAWLNDKSVPSPLNWERKTFSNCNFNM SSLMSFIQADSFTCNNIDAAKIYGMCFS SITIDKFAIPNGRKVDLQLGNLGYLQSF NYRIDTTATSCQLYYNLPAANVSVSRFN PSTWNKRFGFIEDSVFKPRPAGVLTNHD VVYAQHCFKAPKNFCPCKLNGSCVGSGP GKNNGIGTCPAGTNYLTCDNLCTPDPIT FTGTYKCPQTKSLVGIGEHCSGLAVKSD YCGGNSCTCRPQAFLGWSADSCLQGDKC NIFANFILHDVNSGLTCSTDLQKANTDI ILGVCVNYDLYGILGQGIFVEVNATYYN SWQNLLYDSNGNLYGFRDYIINRTFMIR SCYSGRVSAAFHANSSEPALLFRNIKCN YVFNNSLTRQLQPINYFDSYLGCVVNAY NSTAISVQTCDLTVGSGYCVDYSKNRRS RGAITTGYRFTNFEPFTVNSVNDSLEPV GGLYEIQIPSEFTIGNMVEFIQTSSPKV TIDCAAFVCGDYAACKSQLVEYGSFCDN INAILTEVNELLDTTQLQVANSLMNGVT LSTKLKDGVNFNVDDINFSPVLGCLGSE CSKASSRSAIEDLLFDKVKLSDVGFVEA YNNCTGGAEIRDLICVQSYKGIKVLPPL LSENQISGYTLAATSASLFPPWTAAAGV PFYLNVQYRINGLGVTMDVLSQNQKLIA NAFNNALYAIQEGFDATNSALVKIQAVV NANAEALNNLLQQLSNRFGAISASLQEI LSRLDALEAEAQIDRLINGRLTALNAYV SQQLSDSTLVKFSAAQAMEKVNECVKSQ SSRINFCGNGNHIISLVQNAPYGLYFIH FSYVPTKYVTARVSPGLCIAGDRGIAPK SGYFVNVNNTWMYTGSGYYYPEPITENN VVVMSTCAVNYTKAPYVMLNTSIPNLPD FKEELDQWFKNQTSVAPDLSLDYINVTF LDLQVEMNRLQEAIKVLNQSYINLKDIG TYEYYVKWPWYVWLLICLAGVAMLVLLF FICCCTGCGTSCFKKCGGCCDDYTGYQE LVIKTSHDD
Protein Length (aa)	1353

734,00 €

PM-SARS2-S-MUT-1

PepMix™ SARS-CoV-2 (S-MUT)
Pool of 4 peptides derived from a peptide scan through Spike glycoprotein (mutated region) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	4

Further Information:

Amount	1 vial (15 nmol per peptide, appr. 25 ug per peptide)
Specifications	Peptide scan (15mers with 11 aa overlap)
Documentation	Protocol and Datasheet
Swiss-Prot ID	P0DTC2
Sequence	see Datasheet
Protein Length (aa)	27

299,00 €

PM-WCPV-S-RBD

PepMix™ SARS-CoV-2 (S-RBD)
Pool of 53 peptides derived from a peptide scan through Receptor Binding Domain of Spike Glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Receptor Binding Domain of Spike Glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	53

Further Information:

Amount	1 vial (15 nmol per peptide, appr. 25 ug per peptide)
Specifications	Peptide scan (15mers with 11 aa overlap)
Documentation	Protocol and Datasheet
Swiss-Prot ID	P0DTC2, region: 319-541
Sequence	RVQPTESIVRFPNITNLCPFGEVFNATR FASVYAWNRKRISNCVADYSVLYNSASF STFKCYGVSPTKLNDLCFTNVYADSFVI RGDEVRQIAPGQTGKIADYNYKLPDDFT GCVIAWNSNNLDSKVGGNYNYLYRLFRK SNLKPFERDISTEIYQAGSTPCNGVEGF NCYFPLQSYGFQPTNGVGYQPYRVVVLS FELLHAPATVCGPKKSTNLVKNKCVNF
Protein Length (aa)	223

349,00 €

PM-WCPV-S

PepMix™ SARS-CoV-2 (Spike Glycoprotein)
Pool of 315 peptides (delivered in two subpools of 158 & 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)

Technical Data:

Application	Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	158+157

Further Information:

Amount	2 vials (one of each subpool) containing 15 nmol (appr. 25µg) per peptide
Specifications	Peptide scan (15mers with 11 aa overlap)
Documentation	Protocol and Datasheet
Swiss-Prot ID	P0DTC2
Sequence	MFVFLVLLPLVSSQCVNLTTRTQLPPAY TNSFTRGVYYPDKVFRSSVLHSTQDLFL PFFSNVTWFHAIHVSGTNGTKRFDNPVL PFNDGVYFASTEKSNIIRGWIFGTTLDS KTQSLLIVNNATNVVIKVCEFQFCNDPF LGVYYHKNNKSWMESEFRVYSSANNCTF EYVSQPFLMDLEGKQGNFKNLREFVFKN IDGYFKIYSKHTPINLVRDLPQGFSALE PLVDLPIGINITRFQTLLALHRSYLTPG DSSSGWTAGAAAYYVGYLQPRTFLLKYN ENGTITDAVDCALDPLSETKCTLKSFTV EKGIYQTSNFRVQPTESIVRFPNITNLC PFGEVFNATRFASVYAWNRKRISNCVAD YSVLYNSASFSTFKCYGVSPTKLNDLCF TNVYADSFVIRGDEVRQIAPGQTGKIAD YNYKLPDDFTGCVIAWNSNNLDSKVGGN YNYLYRLFRKSNLKPFERDISTEIYQAG STPCNGVEGFNCYFPLQSYGFQPTNGVG YQPYRVVVLSFELLHAPATVCGPKKSTN LVKNKCVNFNFNGLTGTGVLTESNKKFL PFQQFGRDIADTTDAVRDPQTLEILDIT PCSFGGVSVITPGTNTSNQVAVLYQDVN CTEVPVAIHADQLTPTWRVYSTGSNVFQ TRAGCLIGAEHVNNSYECDIPIGAGICA SYQTQTNSPRRARSVASQSIIAYTMSLG AENSVAYSNNSIAIPTNFTISVTTEILP VSMTKTSVDCTMYICGDSTECSNLLLQY GSFCTQLNRALTGIAVEQDKNTQEVFAQ VKQIYKTPPIKDFGGFNFSQILPDPSKP SKRSFIEDLLFNKVTLADAGFIKQYGDC LGDIAARDLICAQKFNGLTVLPPLLTDE MIAQYTSALLAGTITSGWTFGAGAALQI PFAMQMAYRFNGIGVTQNVLYENQKLIA NQFNSAIGKIQDSLSSTASALGKLQDVV NQNAQALNTLVKQLSSNFGAISSVLNDI LSRLDKVEAEVQIDRLITGRLQSLQTYV TQQLIRAAEIRASANLAATKMSECVLGQ SKRVDFCGKGYHLMSFPQSAPHGVVFLH VTYVPAQEKNFTTAPAICHDGKAHFPRE GVFVSNGTHWFVTQRNFYEPQIITTDNT FVSGNCDVVIGIVNNTVYDPLQPELDSF KEELDKYFKNHTSPDVDLGDISGINASV VNIQKEIDRLNEVAKNLNESLIDLQELG KYEQYIKWPWYIWLGFIAGLIAIVMVTI MLCCMTSCCSCLKGCCSCGSCCKFDEDD SEPVLKGVKLHYT
Protein Length (aa)	1273

734,00 €

Antigen Peptides

SP-WCPV-047

SARS-CoV-2 Antigen Peptide SPIKE (AGCLIGAEHVNNSYECDI)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

311,00 €

SP-WCPV-025

SARS-CoV-2 Antigen Peptide SPIKE (ALNTLVKQL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

190,00 €

SP-WCPV-040

SARS-CoV-2 Antigen Peptide SPIKE (AQKFNGLTVLPPLLTDEM)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

311,00 €

SP-WCPV-021

SARS-CoV-2 Antigen Peptide SPIKE (FIAGLIAIV)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

190,00 €

SP-WCPV-022

SARS-CoV-2 Antigen Peptide SPIKE (GAALQIPFAMQMAYRF)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

276,00 €

SP-WCPV-037

SARS-CoV-2 Antigen Peptide SPIKE (KLPDDFTGCV)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

190,00 €

SP-WCPV-027

SARS-CoV-2 Antigen Peptide SPIKE (LITGRLQSL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

190,00 €

SP-WCPV-023

SARS-CoV-2 Antigen Peptide SPIKE (MAYRFNGIGVTQNVLY)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

276,00 €

SP-WCPV-020

SARS-CoV-2 Antigen Peptide SPIKE (NLNESLIDL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

190,00 €

SP-WCPV-024

SARS-CoV-2 Antigen Peptide SPIKE (QALNTLVKQLSSNFGAI)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

294,00 €

SP-WCPV-017

SARS-CoV-2 Antigen Peptide SPIKE (QLIRAAEIRASANLAATK)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

311,00 €

SP-WCPV-019

SARS-CoV-2 Antigen Peptide SPIKE (RLNEVAKNL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

190,00 €

SP-WCPV-038

SARS-CoV-2 Antigen Peptide SPIKE (SIIAYTMSL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

190,00 €

SP-WCPV-039

SARS-CoV-2 Antigen Peptide SPIKE (TECSNLLLQYGSFCTQL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

294,00 €

SP-WCPV-026

SARS-CoV-2 Antigen Peptide SPIKE (VLNDILSRL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

190,00 €

SP-WCPV-018

SARS-CoV-2 Antigen Peptide SPIKE (VVFLHVTYV)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

Technical Data:

Application	Antigen specific T-cell stimulation T-cell assays T-cell expansion
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	1

Further Information:

Amount	1 vial containing 50 µg peptide
Specifications	Peptide as TFA salt
Documentation	Product Datasheet
Swiss-Prot ID	P0DTC2

190,00 €

RepliTope™ Peptide Microarrays

RT-MW-WCPV-Spike

Multiwell RepliTope™ SARS-COV-2 (Spike Glycoprotein)
Peptide microarray displaying 315 peptides derived from a peptide scan through the whole Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2). Incubation with 6 samples (and one control) in parallel using the Array Sl

Technical Data:

Application	Antibody epitope discovery Immune monitoring
Protein Name	Spike glycoprotein
Organism	SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Indication / Topic	Covid-19 Infection Respiratory infection
Number of peptides	315

Further Information:

Amount	1 peptide microarray (each peptide is deposited 3x per subarray, 3x7 subarrays per slide)
Specifications	Peptide scan (15mers with 11 aa overlap)
Documentation	Protocol, Datasheet, gal-file and gal-viewer
Swiss-Prot ID	P0DTC2
Sequence	MFVFLVLLPLVSSQCVNLTTRTQLPPAY TNSFTRGVYYPDKVFRSSVLHSTQDLFL PFFSNVTWFHAIHVSGTNGTKRFDNPVL PFNDGVYFASTEKSNIIRGWIFGTTLDS KTQSLLIVNNATNVVIKVCEFQFCNDPF LGVYYHKNNKSWMESEFRVYSSANNCTF EYVSQPFLMDLEGKQGNFKNLREFVFKN IDGYFKIYSKHTPINLVRDLPQGFSALE PLVDLPIGINITRFQTLLALHRSYLTPG DSSSGWTAGAAAYYVGYLQPRTFLLKYN ENGTITDAVDCALDPLSETKCTLKSFTV EKGIYQTSNFRVQPTESIVRFPNITNLC PFGEVFNATRFASVYAWNRKRISNCVAD YSVLYNSASFSTFKCYGVSPTKLNDLCF TNVYADSFVIRGDEVRQIAPGQTGKIAD YNYKLPDDFTGCVIAWNSNNLDSKVGGN YNYLYRLFRKSNLKPFERDISTEIYQAG STPCNGVEGFNCYFPLQSYGFQPTNGVG YQPYRVVVLSFELLHAPATVCGPKKSTN LVKNKCVNFNFNGLTGTGVLTESNKKFL PFQQFGRDIADTTDAVRDPQTLEILDIT PCSFGGVSVITPGTNTSNQVAVLYQDVN CTEVPVAIHADQLTPTWRVYSTGSNVFQ TRAGCLIGAEHVNNSYECDIPIGAGICA SYQTQTNSPRRARSVASQSIIAYTMSLG AENSVAYSNNSIAIPTNFTISVTTEILP VSMTKTSVDCTMYICGDSTECSNLLLQY GSFCTQLNRALTGIAVEQDKNTQEVFAQ VKQIYKTPPIKDFGGFNFSQILPDPSKP SKRSFIEDLLFNKVTLADAGFIKQYGDC LGDIAARDLICAQKFNGLTVLPPLLTDE MIAQYTSALLAGTITSGWTFGAGAALQI PFAMQMAYRFNGIGVTQNVLYENQKLIA NQFNSAIGKIQDSLSSTASALGKLQDVV NQNAQALNTLVKQLSSNFGAISSVLNDI LSRLDKVEAEVQIDRLITGRLQSLQTYV TQQLIRAAEIRASANLAATKMSECVLGQ SKRVDFCGKGYHLMSFPQSAPHGVVFLH VTYVPAQEKNFTTAPAICHDGKAHFPRE GVFVSNGTHWFVTQRNFYEPQIITTDNT FVSGNCDVVIGIVNNTVYDPLQPELDSF KEELDKYFKNHTSPDVDLGDISGINASV VNIQKEIDRLNEVAKNLNESLIDLQELG KYEQYIKWPWYIWLGFIAGLIAIVMVTI MLCCMTSCCSCLKGCCSCGSCCKFDEDD SEPVLKGVKLHYT
Protein Length (aa)	1273

433,50 €

News

13 NEW Immunopeptidomics Kits

References for MHC I binding HLA peptides to increase accuracy of neo-epitope identification
(Dec 2020)
Read more

Infectious diseases beyond COVID-19

JPT's peptide formats in the literature
(Oct 2020)
Read more

SARS COV-2 Mass Spec Reference Kit Released!:

SARS-CoV-2 SpikeMix for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more

New! SARS-CoV-2 Epitope Mapping Peptide Sets

Save time and samples and check our new SARS-CoV-2 Epitope Mapping Peptide Sets (EMPS).
(Apr 2020)
Read more

> Read more news!

Quality Assurance

All production is performed according to ISO 9001:2015 standards.

CATALOG PRODUCT FINDER

SARS-CoV-2 Spike Products

PepMix™ Peptide Pools

Antigen Peptides

RepliTope™ Peptide Microarrays

News

13 NEW Immunopeptidomics Kits

Infectious diseases beyond COVID-19

SARS COV-2 Mass Spec Reference Kit Released!:

New! SARS-CoV-2 Epitope Mapping Peptide Sets

Quality Assurance

Contact us: